Medprin 迈普医学
Announcement on the Results of the Second Vesting Period of the First Tranche and the First Vesting Period of the Reserved Tranche of the 2024 Restricted Stock Incentive Plan and the Listing of Shares
Stock Code: 301033
Stock Abbreviation: Medprin
Announcement No.: 2026-063
Guangzhou Medprin Regenerative Medical Technology Co., Ltd.
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or significant omissions.
Key Information Prompt:
-
The listing and circulation date of the restricted shares for this vesting is August 3, 2026. The second class of restricted shares for this vesting period has no lock-up period.
-
The number of restricted shares to be vested in this batch is 154,022 shares, accounting for 0.23% of the Company's total share capital (excluding repurchased shares, hereinafter referred to as the same).
-
The number of incentive recipients for this vesting is 28.
-
The source of the restricted shares for this vesting is the Company's ordinary shares of RMB A-shares repurchased from the secondary market.
Guangzhou Medprin Regenerative Medical Technology Co., Ltd. (hereinafter referred to as the "Company") held the 24th meeting of the Third Board of Directors on July 14, 2026, and reviewed and approved the "Proposal on the Fulfillment of Vesting Conditions for the Second Vesting Period of the First Tranche of the 2024 Restricted Stock Incentive Plan" and the "Proposal on the Fulfillment of Vesting Conditions for the First Vesting Period of the Reserved Tranche of the 2024 Restricted Stock Incentive Plan."